First Time Loading...
C

Codiak BioSciences, Inc.
NASDAQ:CDAK

Watchlist Manager
Codiak BioSciences, Inc.
NASDAQ:CDAK
Watchlist
Price: 0.0121 USD -7.63% Market Closed
Updated: May 6, 2024

Codiak BioSciences, Inc.
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Codiak BioSciences, Inc.
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
C
Codiak BioSciences, Inc.
NASDAQ:CDAK
Revenue
$22.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Revenue
$54.3B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.5B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Revenue
$28.2B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$9.9B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.1B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
20%

See Also

What is Codiak BioSciences, Inc.'s Revenue?
Revenue
22.9m USD

Based on the financial report for Dec 31, 2021, Codiak BioSciences, Inc.'s Revenue amounts to 22.9m USD.

What is Codiak BioSciences, Inc.'s Revenue growth rate?
Revenue CAGR 1Y
685%

Over the last year, the Revenue growth was 685%.